Grigoris Effraimidis
Overview
Explore the profile of Grigoris Effraimidis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
494
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Chaniotakis C, Koutserimpas C, Raptis K, Zafeiris E, Alpantaki K, Effraimidis G
J Musculoskelet Neuronal Interact
. 2021 Jun;
21(2):332-334.
PMID: 34059580
No abstract available.
12.
Effraimidis G, Knigge U, Rossing M, Oturai P, Rasmussen A, Feldt-Rasmussen U
Semin Cancer Biol
. 2021 Apr;
79:141-162.
PMID: 33905872
Neuroendocrine neoplasms (NENs) are relatively rare neoplasms with 6.4-times increasing age-adjusted annual incidence during the last four decades. NENs arise from neuroendocrine cells, which release hormones in response to neuronal...
13.
Mathiesen J, Effraimidis G, Rossing M, Rasmussen A, Hoejberg L, Bastholt L, et al.
Semin Cancer Biol
. 2021 Apr;
79:163-179.
PMID: 33812987
Multiple endocrine neoplasias are rare hereditary syndromes some of them with malignant potential. Multiple endocrine neoplasia type 2 (MEN 2) is an autosomal dominant hereditary cancer syndrome due to germline...
14.
Effraimidis G, Watt T, Feldt-Rasmussen U
Front Endocrinol (Lausanne)
. 2021 Apr;
12:641560.
PMID: 33790867
Levothyroxine (L-T4) treatment of overt hypothyroidism can be more challenging in elderly compared to young patients. The elderly population is growing, and increasing incidence and prevalence of hypothyroidism with age...
15.
Feldt-Rasmussen U, Effraimidis G, Klose M
Mol Cell Endocrinol
. 2021 Feb;
525:111173.
PMID: 33549603
The hypothalamus-pituitary-thyroid axis is one of several hormone regulatory systems from the hypothalamus to the pituitary and ultimately to the peripheral target organs. The hypothalamus and the pituitary gland are...
16.
Effraimidis G, Feldt-Rasmussen U, Rasmussen A, Lavoie P, Abaoui M, Boutin M, et al.
J Med Genet
. 2020 Sep;
58(10):692-700.
PMID: 32963035
Introduction: Recent studies showed the usefulness of globotriaosylsphingosine (lyso-Gb) and related analogues, deacylated forms of globotriaosylceramide (Gb), for high-risk screening, treatment monitoring and follow-up for patients with Fabry disease. Methods:...
17.
Effraimidis G, Rasmussen A, Bundgaard H, Sorensen S, Feldt-Rasmussen U
J Inherit Metab Dis
. 2020 Apr;
43(5):922-933.
PMID: 32246457
The identification of pathogenic GLA variants plays a central role in the establishment of a definite Fabry disease (FD) diagnosis. We aimed to review and interpret the published data on...
18.
Alpantaki K, Kampouroglou A, Koutserimpas C, Effraimidis G, Hadjipavlou A
Eur Spine J
. 2019 Jun;
28(9):2129-2144.
PMID: 31201565
Purpose: To examine to what extent diabetes mellitus (DM) is implicated as a distinct mechanism in intervertebral disc degeneration (IVDD). Methods: The published clinical and laboratory data relevant to this...
19.
Effraimidis G
Eur J Endocrinol
. 2019 May;
181(3):R119-R131.
PMID: 31137010
Prediction models are of a great assistance for predicting the development of a disease, detecting or screening undiagnosed patients, predicting the effectiveness of a treatment and helping toward better decision-making....
20.
Paschou S, Palioura E, Kothonas F, Myroforidis A, Loi V, Poulou A, et al.
Endocr J
. 2018 Aug;
65(11):1121-1125.
PMID: 30135331
The aim of this study was to investigate for first time the thyroid function in patients with inflammatory bowel disease (IBD) and the potential effect of anti-TNF (tumor necrosis factor)...